Boyaka PN - Search Results

1

A second generation of double mutant cholera toxin adjuvants: enhanced immunity without intracellular trafficking.

Hagiwara Y, Kawamura YI, Kataoka K, Rahima B, Jackson RJ, Komase K, Dohi T, Boyaka PN, Takeda Y, Kiyono H, McGhee JR, Fujihashi K. Hagiwara Y, et al. Among authors: boyaka pn. J Immunol. 2006 Sep 1;177(5):3045-54. doi: 10.4049/jimmunol.177.5.3045. J Immunol. 2006. PMID: 16920941 Free PMC article.

2

Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit.

Boyaka PN, Ohmura M, Fujihashi K, Koga T, Yamamoto M, Kweon MN, Takeda Y, Jackson RJ, Kiyono H, Yuki Y, McGhee JR. Boyaka PN, et al. J Immunol. 2003 Jan 1;170(1):454-62. doi: 10.4049/jimmunol.170.1.454. J Immunol. 2003. PMID: 12496431

3

Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen.

Boyaka PN, Tafaro A, Fischer R, Leppla SH, Fujihashi K, McGhee JR. Boyaka PN, et al. J Immunol. 2003 Jun 1;170(11):5636-43. doi: 10.4049/jimmunol.170.11.5636. J Immunol. 2003. PMID: 12759444

4

Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens.

Duverger A, Jackson RJ, van Ginkel FW, Fischer R, Tafaro A, Leppla SH, Fujihashi K, Kiyono H, McGhee JR, Boyaka PN. Duverger A, et al. Among authors: boyaka pn. J Immunol. 2006 Feb 1;176(3):1776-83. doi: 10.4049/jimmunol.176.3.1776. J Immunol. 2006. PMID: 16424208

5

Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4.

Marinaro M, Staats HF, Hiroi T, Jackson RJ, Coste M, Boyaka PN, Okahashi N, Yamamoto M, Kiyono H, Bluethmann H, Fujihashi K, McGhee JR. Marinaro M, et al. Among authors: boyaka pn. J Immunol. 1995 Nov 15;155(10):4621-9. J Immunol. 1995. PMID: 7594461

6

Interleukin-12 alters helper T-cell subsets and antibody profiles induced by the mucosal adjuvant cholera toxin.

Marinaro M, Boyaka PN, Jackson RJ, Finkelman FD, Kiyono H, McGhee JR. Marinaro M, et al. Among authors: boyaka pn. Ann N Y Acad Sci. 1996 Oct 31;795:361-5. doi: 10.1111/j.1749-6632.1996.tb52693.x. Ann N Y Acad Sci. 1996. PMID: 8958955

7

Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin.

Marinaro M, Boyaka PN, Jackson RJ, Finkelman FD, Kiyono H, Jirillo E, McGhee JR. Marinaro M, et al. Among authors: boyaka pn. J Immunol. 1999 Jan 1;162(1):114-21. J Immunol. 1999. PMID: 9886376

8

IL-12 is an effective adjuvant for induction of mucosal immunity.

Boyaka PN, Marinaro M, Jackson RJ, Menon S, Kiyono H, Jirillo E, McGhee JR. Boyaka PN, et al. J Immunol. 1999 Jan 1;162(1):122-8. J Immunol. 1999. PMID: 9886377

9

Lymphotactin acts as an innate mucosal adjuvant.

Lillard JW Jr, Boyaka PN, Hedrick JA, Zlotnik A, McGhee JR. Lillard JW Jr, et al. Among authors: boyaka pn. J Immunol. 1999 Feb 15;162(4):1959-65. J Immunol. 1999. PMID: 9973465

10

Oral QS-21 requires early IL-4 help for induction of mucosal and systemic immunity.

Boyaka PN, Marinaro M, Jackson RJ, van Ginkel FW, Cormet-Boyaka E, Kirk KL, Kensil CR, McGhee JR. Boyaka PN, et al. J Immunol. 2001 Feb 15;166(4):2283-90. doi: 10.4049/jimmunol.166.4.2283. J Immunol. 2001. PMID: 11160283

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters